Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Pittsburgh
Brain Inflammation Collaborative
M.D. Anderson Cancer Center
Radboud University Medical Center
Odense University Hospital